Chemed Corp (CHE) stock
CHENYSEServices-Home Health Care ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 17/306% above fair value
$546.75−2.70 (-0.49%)
Close on Nov 17, 2026Market cap $7.12BP/E 26.1Yield 0.40%
Chemed revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Chemed's revenue for the twelve months ending Sep 30, 2026 was $2.66B, up 5.2% year over year. For fiscal 2025 it was $2.53B, up 4.1% from the year before. Over ten years it grew 5.1% a year on average. The highest annual figure on record is $2.53B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.53B | +4.1% |
| FY2024 | Dec 31, 2024 | $2.43B | +7.4% |
| FY2023 | Dec 31, 2023 | $2.26B | +6.1% |
| FY2022 | Dec 31, 2022 | $2.13B | -0.2% |
| FY2021 | Dec 31, 2021 | $2.14B | +2.9% |
| FY2020 | Dec 31, 2020 | $2.08B | +7.3% |
| FY2019 | Dec 31, 2019 | $1.94B | +8.7% |
| FY2018 | Dec 31, 2018 | $1.78B | +7.0% |
| FY2017 | Dec 31, 2017 | $1.67B | +5.7% |
| FY2016 | Dec 31, 2016 | $1.58B | +2.2% |
| FY2015 | Dec 31, 2015 | $1.54B | +6.0% |
| FY2014 | Dec 31, 2014 | $1.46B | +3.0% |
| FY2013 | Dec 31, 2013 | $1.41B | -1.2% |
| FY2012 | Dec 31, 2012 | $1.43B | +5.5% |
| FY2011 | Dec 31, 2011 | $1.36B | +5.9% |
| FY2010 | Dec 31, 2010 | $1.28B | +7.6% |
| FY2009 | Dec 31, 2009 | $1.19B | +3.6% |
| FY2008 | Dec 31, 2008 | $1.15B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $690.94M | +10.6% |
| Q2 FY2026 | Jun 30, 2026 | $673.25M | +8.8% |
| Q1 FY2026 | Mar 31, 2026 | $657.51M | +1.6% |
| Q4 FY2025 | Dec 31, 2025 | $639.34M | -0.1% |
| Q3 FY2025 | Sep 30, 2025 | $624.90M | +3.1% |
| Q2 FY2025 | Jun 30, 2025 | $618.80M | +3.8% |
| Q1 FY2025 | Mar 31, 2025 | $646.94M | +9.8% |
| Q4 FY2024 | Dec 31, 2024 | $639.99M | +9.2% |
| Q3 FY2024 | Sep 30, 2024 | $606.18M | +7.4% |
| Q2 FY2024 | Jun 30, 2024 | $595.88M | +7.6% |
| Q1 FY2024 | Mar 31, 2024 | $589.23M | +5.2% |
| Q4 FY2023 | Dec 31, 2023 | $585.91M | +7.2% |
| Q3 FY2023 | Sep 30, 2023 | $564.53M | +7.2% |
| Q2 FY2023 | Jun 30, 2023 | $553.82M | +4.2% |
| Q1 FY2023 | Mar 31, 2023 | $560.16M | +5.6% |
| Q4 FY2022 | Dec 31, 2022 | $546.65M | +1.0% |
| Q3 FY2022 | Sep 30, 2022 | $526.47M | -2.3% |
| Q2 FY2022 | Jun 30, 2022 | $531.29M | -0.2% |
| Q1 FY2022 | Mar 31, 2022 | $530.55M | +0.6% |
| Q4 FY2021 | Dec 31, 2021 | $540.98M | +1.4% |
| Q3 FY2021 | Sep 30, 2021 | $538.67M | +2.0% |
| Q2 FY2021 | Jun 30, 2021 | $532.26M | +6.0% |
| Q1 FY2021 | Mar 31, 2021 | $527.36M | +2.2% |
| Q4 FY2020 | Dec 31, 2020 | $533.29M | +2.1% |
| Q3 FY2020 | Sep 30, 2020 | $528.30M | +9.9% |
| Q2 FY2020 | Jun 30, 2020 | $502.20M | +6.0% |
| Q1 FY2020 | Mar 31, 2020 | $515.80M | +11.6% |
| Q4 FY2019 | Dec 31, 2019 | $522.32M | +14.2% |
| Q3 FY2019 | Sep 30, 2019 | $480.61M | +8.2% |
| Q2 FY2019 | Jun 30, 2019 | $473.58M | +7.2% |
| Q1 FY2019 | Mar 31, 2019 | $462.03M | +5.2% |
| Q4 FY2018 | Dec 31, 2018 | $457.51M | +6.8% |
| Q3 FY2018 | Sep 30, 2018 | $444.15M | +6.4% |
| Q2 FY2018 | Jun 30, 2018 | $441.81M | +6.4% |
| Q1 FY2018 | Mar 31, 2018 | $439.18M | +8.2% |
| Q4 FY2017 | Dec 31, 2017 | $428.36M | +6.2% |
| Q3 FY2017 | Sep 30, 2017 | $417.44M | – |
| Q2 FY2017 | Jun 30, 2017 | $415.06M | – |
| Q1 FY2017 | Mar 31, 2017 | $405.86M | – |
| Q4 FY2016 | Dec 31, 2016 | $403.48M | – |
See a number that looks wrong?